Accuracy and upgrade rates of percutaneous breast biopsy: The surgeon's role

Windy Olaya, Won Bae, Jan Wong, Jasmine Wong, Sharmila Roy-Chowdhury, Kevork Kazanjian, Sharon Lum

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We sought to evaluate the impact of needle core size and number of core samples on diagnostic accuracy and upgrade rates for image-guided core needle biopsies of the breast. A total of 234 patients underwent image-guided percutaneous needle biopsies and subsequent surgical excision. Large-core needles (9 gauge or less) were used in 14.5 per cent of cases and the remainder were performed with smaller core needles. More than four core samples were taken in 78.9 per cent of patients. In 71.8 per cent of cases, needle biopsy pathology matched surgical excision pathology. After surgical excision, upgraded pathology was revealed in 10.7 per cent of cases. Of 11 patients (52.4%) with benign needle core pathology who had upgraded final pathology on surgical excision, 10 had a Breast Imaging Recording and Data System score 4 or 5 imaging study. Lesions smaller than 10 mm were more likely to be misdiagnosed (P = 0.01) or have upgraded pathology (P = 0.009). Other predictors of upgraded pathology were patient age 50 years or older (P = 0.03) and taking four or fewer core samples (P = 0.003). Needle core size did not impact accuracy or upgrade rates. Surgeons should exercise caution when interpreting needle biopsy results with older patients, smaller lesions, and limited sampling. Discordant pathology and imaging still mandate surgical confirmation.

Original languageEnglish (US)
Pages (from-to)1084-1087
Number of pages4
JournalAmerican Surgeon
Volume76
Issue number10
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Breast
Needles
Pathology
Biopsy
Needle Biopsy
Surgical Pathology
Large-Core Needle Biopsy
Diagnostic Errors
Information Systems
Surgeons
Exercise

ASJC Scopus subject areas

  • Surgery

Cite this

Olaya, W., Bae, W., Wong, J., Wong, J., Roy-Chowdhury, S., Kazanjian, K., & Lum, S. (2010). Accuracy and upgrade rates of percutaneous breast biopsy: The surgeon's role. American Surgeon, 76(10), 1084-1087.

Accuracy and upgrade rates of percutaneous breast biopsy : The surgeon's role. / Olaya, Windy; Bae, Won; Wong, Jan; Wong, Jasmine; Roy-Chowdhury, Sharmila; Kazanjian, Kevork; Lum, Sharon.

In: American Surgeon, Vol. 76, No. 10, 10.2010, p. 1084-1087.

Research output: Contribution to journalArticle

Olaya, W, Bae, W, Wong, J, Wong, J, Roy-Chowdhury, S, Kazanjian, K & Lum, S 2010, 'Accuracy and upgrade rates of percutaneous breast biopsy: The surgeon's role', American Surgeon, vol. 76, no. 10, pp. 1084-1087.
Olaya W, Bae W, Wong J, Wong J, Roy-Chowdhury S, Kazanjian K et al. Accuracy and upgrade rates of percutaneous breast biopsy: The surgeon's role. American Surgeon. 2010 Oct;76(10):1084-1087.
Olaya, Windy ; Bae, Won ; Wong, Jan ; Wong, Jasmine ; Roy-Chowdhury, Sharmila ; Kazanjian, Kevork ; Lum, Sharon. / Accuracy and upgrade rates of percutaneous breast biopsy : The surgeon's role. In: American Surgeon. 2010 ; Vol. 76, No. 10. pp. 1084-1087.
@article{27bc4be7c8fc40e28a35db3bacf2f1fa,
title = "Accuracy and upgrade rates of percutaneous breast biopsy: The surgeon's role",
abstract = "We sought to evaluate the impact of needle core size and number of core samples on diagnostic accuracy and upgrade rates for image-guided core needle biopsies of the breast. A total of 234 patients underwent image-guided percutaneous needle biopsies and subsequent surgical excision. Large-core needles (9 gauge or less) were used in 14.5 per cent of cases and the remainder were performed with smaller core needles. More than four core samples were taken in 78.9 per cent of patients. In 71.8 per cent of cases, needle biopsy pathology matched surgical excision pathology. After surgical excision, upgraded pathology was revealed in 10.7 per cent of cases. Of 11 patients (52.4{\%}) with benign needle core pathology who had upgraded final pathology on surgical excision, 10 had a Breast Imaging Recording and Data System score 4 or 5 imaging study. Lesions smaller than 10 mm were more likely to be misdiagnosed (P = 0.01) or have upgraded pathology (P = 0.009). Other predictors of upgraded pathology were patient age 50 years or older (P = 0.03) and taking four or fewer core samples (P = 0.003). Needle core size did not impact accuracy or upgrade rates. Surgeons should exercise caution when interpreting needle biopsy results with older patients, smaller lesions, and limited sampling. Discordant pathology and imaging still mandate surgical confirmation.",
author = "Windy Olaya and Won Bae and Jan Wong and Jasmine Wong and Sharmila Roy-Chowdhury and Kevork Kazanjian and Sharon Lum",
year = "2010",
month = "10",
language = "English (US)",
volume = "76",
pages = "1084--1087",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "10",

}

TY - JOUR

T1 - Accuracy and upgrade rates of percutaneous breast biopsy

T2 - The surgeon's role

AU - Olaya, Windy

AU - Bae, Won

AU - Wong, Jan

AU - Wong, Jasmine

AU - Roy-Chowdhury, Sharmila

AU - Kazanjian, Kevork

AU - Lum, Sharon

PY - 2010/10

Y1 - 2010/10

N2 - We sought to evaluate the impact of needle core size and number of core samples on diagnostic accuracy and upgrade rates for image-guided core needle biopsies of the breast. A total of 234 patients underwent image-guided percutaneous needle biopsies and subsequent surgical excision. Large-core needles (9 gauge or less) were used in 14.5 per cent of cases and the remainder were performed with smaller core needles. More than four core samples were taken in 78.9 per cent of patients. In 71.8 per cent of cases, needle biopsy pathology matched surgical excision pathology. After surgical excision, upgraded pathology was revealed in 10.7 per cent of cases. Of 11 patients (52.4%) with benign needle core pathology who had upgraded final pathology on surgical excision, 10 had a Breast Imaging Recording and Data System score 4 or 5 imaging study. Lesions smaller than 10 mm were more likely to be misdiagnosed (P = 0.01) or have upgraded pathology (P = 0.009). Other predictors of upgraded pathology were patient age 50 years or older (P = 0.03) and taking four or fewer core samples (P = 0.003). Needle core size did not impact accuracy or upgrade rates. Surgeons should exercise caution when interpreting needle biopsy results with older patients, smaller lesions, and limited sampling. Discordant pathology and imaging still mandate surgical confirmation.

AB - We sought to evaluate the impact of needle core size and number of core samples on diagnostic accuracy and upgrade rates for image-guided core needle biopsies of the breast. A total of 234 patients underwent image-guided percutaneous needle biopsies and subsequent surgical excision. Large-core needles (9 gauge or less) were used in 14.5 per cent of cases and the remainder were performed with smaller core needles. More than four core samples were taken in 78.9 per cent of patients. In 71.8 per cent of cases, needle biopsy pathology matched surgical excision pathology. After surgical excision, upgraded pathology was revealed in 10.7 per cent of cases. Of 11 patients (52.4%) with benign needle core pathology who had upgraded final pathology on surgical excision, 10 had a Breast Imaging Recording and Data System score 4 or 5 imaging study. Lesions smaller than 10 mm were more likely to be misdiagnosed (P = 0.01) or have upgraded pathology (P = 0.009). Other predictors of upgraded pathology were patient age 50 years or older (P = 0.03) and taking four or fewer core samples (P = 0.003). Needle core size did not impact accuracy or upgrade rates. Surgeons should exercise caution when interpreting needle biopsy results with older patients, smaller lesions, and limited sampling. Discordant pathology and imaging still mandate surgical confirmation.

UR - http://www.scopus.com/inward/record.url?scp=78651372313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651372313&partnerID=8YFLogxK

M3 - Article

C2 - 21105615

AN - SCOPUS:78651372313

VL - 76

SP - 1084

EP - 1087

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 10

ER -